JPRN-UMIN000015726招募中未知
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseases - Intraocular tissue plasminogen activator administration in various eye diseases
Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan0 个研究点目标入组 50 人开始时间: 2014年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Medical history of hemorrhagic disorder
研究者
相似试验
招募中
不适用
Study of the efficacy and safety of intra-retinal arterial fibrinolysis for central retinal artery occlusioCentral Retinal Artery Occlusion(CRAO)JPRN-UMIN000022972Yokohama City University10
未知
不适用
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000025361ara Medical University20
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
已完成
不适用
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous ChorioretinopathyIRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30
进行中（未招募）
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE